Cancer Crosslinks 2022
CCBIO's partner Oslo Cancer Cluster invites to their annual event Cancer Crosslinks, January 27, 2022, with the overarching theme Getting Ahead of Tumor Evolution - Changing the Premises in the War Against Cancer. Cancer Crosslinks 2022 will be A Digital/Hybrid Event streamed from Oslo Cancer Cluster Innovation Park. There is an option to attend on-site pending COVID-19 guidelines.
Cancer Crosslinks is an annual educational meeting which gathers prominent experts in oncology, providing a forum for networking and interaction. Gain new insights and engage with distinguished speakers as they address progress in cancer diagnostics and treatments.
Mariam Jamal-Hanjani, Group Leader, Cancer Metastasis Lab, CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute. Senior Clinical Lecturer and Honorary Consultant in Translational Lung Oncology, UCL Hospital. Visiting Scientist, The Francis Crick Institute, London, UK
David Rimm, Anthony N. Brady Professor of Pathology, Professor of Medicine (Oncology), Director, Translational Pathology and Director, Yale Pathology Tissue Services; Director, Physician Scientist Training Program in Pathology, Yale University School of Medicine, New Haven, USA
Martin Schuler, Professor, Director Department of Medical Oncology, University Hospital Essen; Spokesman for the German Cancer Consortium (DKTK), Partner Site University Hospital, Essen, Germany
Angela George, Clinical Director of Genomics and Consultant Medical Oncologist in Gynecology, Royal Marsden Hospital, London, UK
Christoph Driessen, Professor, Head of Clinical Trial Unit, Department of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland
Bertrand Routy, Assistant Professor of Hemato-Oncology, Centre de recherche, Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Canada
Registration: Register here. Access link will be provided to registered participants.
Organizer contact: firstname.lastname@example.org